cdc emerging markets limited
cdc emerging markets limited Company Information
Company Number
03830059
Next Accounts
Sep 2025
Shareholders
british international investment plc
Group Structure
View All
Industry
Activities of venture and development capital companies
Registered Address
123 victoria street, london, SW1E 6DE
Website
https://www.bii.co.uk/cdc emerging markets limited Estimated Valuation
Pomanda estimates the enterprise value of CDC EMERGING MARKETS LIMITED at £7.9m based on a Turnover of £2.7m and 2.95x industry multiple (adjusted for size and gross margin).
cdc emerging markets limited Estimated Valuation
Pomanda estimates the enterprise value of CDC EMERGING MARKETS LIMITED at £0 based on an EBITDA of £-589.8k and a 7.15x industry multiple (adjusted for size and gross margin).
cdc emerging markets limited Estimated Valuation
Pomanda estimates the enterprise value of CDC EMERGING MARKETS LIMITED at £0 based on Net Assets of £-930.4k and 1.17x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cdc Emerging Markets Limited Overview
Cdc Emerging Markets Limited is a live company located in london, SW1E 6DE with a Companies House number of 03830059. It operates in the activities of venture and development capital companies sector, SIC Code 64303. Founded in August 1999, it's largest shareholder is british international investment plc with a 100% stake. Cdc Emerging Markets Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.7m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cdc Emerging Markets Limited Health Check
Pomanda's financial health check has awarded Cdc Emerging Markets Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
4 Weak
Size
annual sales of £2.7m, make it larger than the average company (£2m)
£2.7m - Cdc Emerging Markets Limited
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of -40%, show it is growing at a slower rate (4.3%)
-40% - Cdc Emerging Markets Limited
4.3% - Industry AVG
Production
with a gross margin of 83.7%, this company has a comparable cost of product (83.7%)
83.7% - Cdc Emerging Markets Limited
83.7% - Industry AVG
Profitability
an operating margin of -22% make it less profitable than the average company (1.7%)
-22% - Cdc Emerging Markets Limited
1.7% - Industry AVG
Employees
with 14 employees, this is above the industry average (9)
- Cdc Emerging Markets Limited
9 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Cdc Emerging Markets Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £191.7k, this is equally as efficient (£204.6k)
- Cdc Emerging Markets Limited
£204.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cdc Emerging Markets Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cdc Emerging Markets Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cdc Emerging Markets Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (46 weeks)
7 weeks - Cdc Emerging Markets Limited
46 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 106.9%, this is a higher level of debt than the average (50.1%)
106.9% - Cdc Emerging Markets Limited
50.1% - Industry AVG
CDC EMERGING MARKETS LIMITED financials
Cdc Emerging Markets Limited's latest turnover from December 2023 is £2.7 million and the company has net assets of -£930.4 thousand. According to their latest financial statements, we estimate that Cdc Emerging Markets Limited has 14 employees and maintains cash reserves of £2.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 2,683,869 | 5,159,833 | 12,019,852 | 12,615,081 | 11,709,908 | 11,754,482 | 14,009,972 | 7,951,773 | 639,359 | ||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | -589,790 | -1,062,170 | 3,332,563 | ||||||||||||
| Interest Payable | 1,736,935 | 3,640,398 | 7,955,666 | 8,476,624 | 7,861,010 | 8,943,762 | 9,667,992 | 6,361,767 | 2,192,682 | 47,216 | |||||
| Interest Receivable | 234 | 76 | 1,890,244 | 639,358 | |||||||||||
| Pre-Tax Profit | -3,090,348 | -5,385,199 | -9,899,043 | -2,780,673 | 7,414,500 | -3,386,092 | -8,288,820 | -2,804,793 | -2,123,780 | -51,046 | |||||
| Tax | -58,219 | -280,111 | -74,299 | -577,392 | -603,355 | -496,556 | -1,386,598 | -399,925 | -31,968 | ||||||
| Profit After Tax | -3,148,567 | -5,665,310 | -9,973,342 | -3,358,066 | 6,811,144 | -3,882,648 | -9,675,417 | -3,204,719 | -2,155,748 | -51,046 | |||||
| Dividends Paid | |||||||||||||||
| Retained Profit | -3,148,567 | -5,665,310 | -9,973,342 | -3,358,066 | 6,811,144 | -3,882,648 | -9,675,417 | -3,204,719 | -2,155,748 | -51,046 | |||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* | -589,790 | -1,062,170 | 3,332,563 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 11,145,740 | 12,550,928 | 55,953,199 | 97,135,768 | 90,328,230 | 88,871,221 | 102,958,615 | 109,108,686 | 71,530,236 | ||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 11,145,740 | 12,550,928 | 55,953,199 | 97,135,768 | 90,328,229 | 88,871,220 | 102,958,614 | 109,108,686 | 71,530,236 | ||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 11,145,740 | 12,550,928 | 55,953,199 | 97,135,768 | 90,328,229 | 88,871,220 | 102,958,614 | 109,108,686 | 71,530,236 | ||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 7,488,934 | ||||||||||||||
| Misc Debtors | 243,644 | 243,358 | 3,100,767 | 4,889,553 | 2,923,413 | 2,814,281 | 1,973,234 | 1,890,244 | 639,358 | ||||||
| Cash | 2,130,807 | 901,556 | 30,518,785 | 2,222,753 | 6,715,733 | 6,343,937 | 11,325,515 | 8,264,597 | 1,044,918 | 18,474,349 | |||||
| misc current assets | 408,914 | 75,802 | |||||||||||||
| total current assets | 2,374,453 | 1,207,809 | 33,959,603 | 7,178,899 | 9,639,147 | 16,647,153 | 13,298,750 | 10,563,757 | 1,760,080 | 18,474,349 | |||||
| total assets | 13,520,193 | 13,758,737 | 89,912,802 | 104,314,667 | 99,967,376 | 105,518,373 | 116,257,364 | 119,672,443 | 73,290,316 | 18,474,349 | |||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 14,450,548 | 11,540,526 | 81,842,905 | 85,651,370 | 80,263,883 | 91,621,951 | 9,216,638 | 7,511,292 | 2,311,044 | 58,779 | |||||
| total current liabilities | 14,450,549 | 11,540,527 | 81,842,906 | 85,651,371 | 80,263,885 | 91,621,952 | 9,216,640 | 7,511,293 | 2,311,046 | 58,780 | |||||
| loans | 79,678,593 | 82,274,629 | 51,231,412 | 12,926,810 | |||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 79,678,593 | 82,274,629 | 51,231,412 | 12,926,810 | |||||||||||
| total liabilities | 14,450,549 | 11,540,527 | 81,842,906 | 85,651,371 | 80,263,885 | 91,621,952 | 88,895,233 | 89,785,922 | 53,542,458 | 12,985,590 | |||||
| net assets | -930,357 | 2,218,210 | 8,069,896 | 18,663,296 | 19,703,491 | 13,896,421 | 27,362,131 | 29,886,520 | 19,747,858 | 5,488,759 | |||||
| total shareholders funds | -930,357 | 2,218,210 | 8,069,896 | 18,663,296 | 19,703,492 | 13,896,422 | 27,362,131 | 29,886,520 | 19,747,858 | 5,488,759 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -589,790 | -1,062,170 | 3,332,563 | ||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | -58,219 | -280,111 | -74,299 | -577,392 | -603,355 | -496,556 | -1,386,598 | -399,925 | -31,968 | ||||||
| Stock | |||||||||||||||
| Debtors | 286 | -2,857,409 | -1,788,786 | 1,966,140 | -7,379,802 | 8,329,981 | 82,990 | 1,250,886 | 639,358 | ||||||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | 2,910,022 | -70,302,379 | -3,808,465 | 5,387,487 | -11,358,068 | 82,405,313 | 1,705,346 | 5,200,248 | 2,252,265 | 58,779 | |||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | 2,261,727 | -68,787,251 | 1,238,585 | ||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -1,405,188 | -43,402,271 | -41,182,569 | 6,807,539 | 1,457,009 | -14,087,394 | -6,150,072 | 37,578,450 | 71,530,236 | ||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -1 | 1 | -1 | 1 | -1 | 1 | 1 | ||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -79,678,593 | -2,596,036 | 31,043,217 | 38,304,602 | 12,926,810 | ||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -1,736,935 | -3,640,164 | -7,955,666 | -8,476,548 | -7,861,010 | -8,943,762 | -9,667,992 | -4,471,523 | -1,553,324 | -47,216 | |||||
| cash flow from financing | -1,736,935 | -3,826,541 | -8,575,723 | -6,158,679 | -8,865,083 | -98,205,417 | -5,113,000 | 39,915,077 | 53,166,125 | 18,419,400 | |||||
| cash and cash equivalents | |||||||||||||||
| cash | 1,229,251 | -29,617,229 | 28,296,032 | -4,492,980 | 371,796 | -4,981,578 | 3,060,918 | 7,219,679 | -17,429,431 | 18,474,349 | |||||
| overdraft | |||||||||||||||
| change in cash | 1,229,251 | -29,617,229 | 28,296,032 | -4,492,980 | 371,796 | -4,981,578 | 3,060,918 | 7,219,679 | -17,429,431 | 18,474,349 |
cdc emerging markets limited Credit Report and Business Information
Cdc Emerging Markets Limited Competitor Analysis
Perform a competitor analysis for cdc emerging markets limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other small companies, companies in SW1E area or any other competitors across 12 key performance metrics.
cdc emerging markets limited Ownership
CDC EMERGING MARKETS LIMITED group structure
Cdc Emerging Markets Limited has no subsidiary companies.
Ultimate parent company
1 parent
CDC EMERGING MARKETS LIMITED
03830059
cdc emerging markets limited directors
Cdc Emerging Markets Limited currently has 2 directors. The longest serving directors include Mr Colin Buckley (Sep 2019) and Mrs Carolyn Sims (Sep 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Colin Buckley | United Kingdom | 64 years | Sep 2019 | - | Director |
| Mrs Carolyn Sims | 59 years | Sep 2020 | - | Director |
P&L
December 2023turnover
2.7m
-48%
operating profit
-589.8k
-44%
gross margin
83.7%
+0.05%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-930.4k
-1.42%
total assets
13.5m
-0.02%
cash
2.1m
+1.36%
net assets
Total assets minus all liabilities
cdc emerging markets limited company details
company number
03830059
Type
Private limited with Share Capital
industry
64303 - Activities of venture and development capital companies
incorporation date
August 1999
age
26
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
trushelfco (no.2527) limited (October 1999)
accountant
-
auditor
DELOITTE LLP
address
123 victoria street, london, SW1E 6DE
Bank
-
Legal Advisor
-
cdc emerging markets limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cdc emerging markets limited.
cdc emerging markets limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CDC EMERGING MARKETS LIMITED. This can take several minutes, an email will notify you when this has completed.
cdc emerging markets limited Companies House Filings - See Documents
| date | description | view/download |
|---|
